Profile | GDS4284 / 213207_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 878.687 | 72 |
GSM687648 | Patient 402 control | 1029.94 | 74 |
GSM687653 | Patient 403 control | 1057.44 | 75 |
GSM687658 | Patient 404 control | 957.984 | 73 |
GSM687663 | Patient 411 control | 1251.67 | 77 |
GSM687668 | Patient 422 control | 1040.38 | 74 |
GSM687673 | Patient 424 control | 1218.04 | 77 |
GSM687678 | Patient 425 control | 955.325 | 72 |
GSM687683 | Patient 427 control | 1176.56 | 76 |
GSM687688 | Patient 428 control | 923.599 | 73 |
GSM687695 | Patient 441 control | 818.761 | 72 |
GSM687699 | Patient 443 control | 1285.25 | 78 |
GSM687704 | Patient 444 control | 1147.19 | 76 |
GSM687707 | Patient 448 control | 1183.9 | 77 |
GSM687712 | Patient 449 control | 1326.48 | 78 |
GSM687719 | Patient 450 control | 1055.15 | 75 |
GSM687724 | Patient 451 control | 945.659 | 74 |
GSM687728 | Patient 452 control | 1563.69 | 81 |
GSM687646 | Patient 401 treated 24h | 944.238 | 73 |
GSM687649 | Patient 402 treated 24h | 1058.42 | 75 |
GSM687665 | Patient 411 treated 24h | 1295.01 | 78 |
GSM687651 | Patient 402 treated 4 weeks | 1506.97 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 1532.98 | 80 |
GSM687670 | Patient 422 treated 24h | 1345.47 | 78 |
GSM687671 | Patient 422 treated 4 weeks | 995.628 | 73 |
GSM687654 | Patient 403 treated 24h | 984.179 | 74 |
GSM687675 | Patient 424 treated 24h | 1243.97 | 77 |
GSM687685 | Patient 427 treated 24h | 1026.01 | 74 |
GSM687656 | Patient 403 treated 4 weeks | 1130.29 | 76 |
GSM687677 | Patient 424 treated 4 weeks | 881.851 | 72 |
GSM687687 | Patient 427 treated 4 weeks | 742.121 | 69 |
GSM687692 | Patient 428 treated 4h | 978.882 | 74 |
GSM687716 | Patient 449 treated 4h | 850.469 | 72 |
GSM687722 | Patient 450 treated 4h | 890.858 | 72 |
GSM687680 | Patient 425 treated 24h | 1199.9 | 76 |
GSM687690 | Patient 428 treated 24h | 1116.71 | 76 |
GSM687700 | Patient 443 treated 24h | 988.228 | 73 |
GSM687705 | Patient 444 treated 24h | 1206.2 | 77 |
GSM687714 | Patient 449 treated 24h | 999.069 | 74 |
GSM687721 | Patient 450 treated 24h | 1387.7 | 79 |
GSM687682 | Patient 425 treated 4 weeks | 592.658 | 67 |
GSM687694 | Patient 428 treated 4 weeks | 1189.13 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 1332.64 | 78 |
GSM687718 | Patient 449 treated 4 weeks | 758.866 | 70 |
GSM687723 | Patient 450 treated 4 weeks | 1736.11 | 82 |
GSM687661 | Patient 404 treated 4h | 1263.18 | 77 |
GSM687710 | Patient 448 treated 4h | 1139.07 | 77 |
GSM687726 | Patient 451 treated 4h | 1283.25 | 78 |
GSM687730 | Patient 452 treated 4h | 1109.65 | 76 |
GSM687660 | Patient 404 treated 24h | 654.247 | 69 |
GSM687697 | Patient 441 treated 24h | 708.733 | 69 |
GSM687709 | Patient 448 treated 24h | 1167.34 | 77 |
GSM687725 | Patient 451 treated 24h | 1361.29 | 79 |
GSM687729 | Patient 452 treated 24h | 845.618 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 1086.11 | 75 |
GSM687731 | Patient 452 treated 4 weeks | 2053.73 | 84 |